Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Justin Hanes
Johns Hopkins University, Department: Ophthalmology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Kala Pharmaceuticals, Inc.
Payment for services (e.g., consulting fees, honoraria, paid authorship)
The SFIs are related in that their values could be affected by the research. Upon review by the institution, it was determined that Dr. Hanes’ SFIs could directly and significantly affect the design, conduct or reporting of his research under this award.
Biodegradable Mucus Penetrating DNA Nanoparticle for Gene Therapy of CF
The gene that could cure cystic fibrosis (CF) has been available since 1989, yet no one has been cured; damage to the lungs is the primary source of morbidity and mortality in CF patients. We found that none of the gene delivery systems used in CF gene therapy clinical trials to date, including various viruses, are capable of overcoming the three foremost barriers to successful gene therapy in the airways: mucus gel barrier, periciliary layer barrier, and airway cell uptake barrier. We seek to test novel gene vectors in combination with a novel aqueous vehicle that we hypothesize will greatly enhance the effectiveness of gene transfer in the lungs.
Filed on November 18, 2016.
Tell us what you know about Justin Hanes's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Justin Hanes filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Justin Hanes | Johns Hopkins University | Conflict of Interest | Kala Pharmaceuticals, Inc. | $60,000 - $79,999 |
| Justin Hanes | Johns Hopkins University | Conflict of Interest | GrayBug, Inc. | $60,000 - $79,999 |
| Justin Hanes | Johns Hopkins University | Conflict of Interest | Kala Pharmaceuticals, Inc. | Value cannot be readily determined |
| Justin Hanes | Johns Hopkins University | Conflict of Interest | GrayBug, Inc. | Value cannot be readily determined |
| Justin Hanes | Johns Hopkins University | Conflict of Interest | GrayBug, Inc. | Value cannot be readily determined |
| Justin Hanes | Johns Hopkins University | Conflict of Interest | Kala Pharmaceuticals, Inc. | Value cannot be readily determined |
| Justin Hanes | Johns Hopkins University | Conflict of Interest | Kala Pharmaceuticals, Inc. | Value cannot be readily determined |
| Justin Hanes | Johns Hopkins University | Conflict of Interest | Kala Pharmaceuticals, Inc. | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.